The SPUR PRAM (patient-reported adherence measure) was developed over 2021 and 2022 via a series of studies in Europe and the United States. Based on the initial SPUR theoretical framework first ...
Prior to analysis, we applied rigorous quality control (QC) measures by filtering autosomal variants against the 1000 Genomes Project Phase 3 European reference panel 25. Exclusion criteria removed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results